Ashish Pemawat: The INSTANT Trial Opens New Questions in Acute Stroke Therapy
Ashish Pemawat, Associate Director of Institute of Neurosciences, shared on LinkedIn about a recent article by INSTANT Trial Authors, published in JAMA, adding:
”Can adjunctive tirofiban improve outcomes after intravenous thrombolysis? The INSTANT Trial offers an intriguing perspective.
The recently published INSTANT Trial in JAMA evaluated intravenous tirofiban after tenecteplase in patients with acute ischemic stroke who had no large- or medium-vessel occlusion and no cardioembolic source.
The study demonstrated a higher rate of excellent functional outcomes at 90 days with tirofiban (mRS 0–1: 63.8% vs. 52.2%) without a significant increase in serious safety events.
While these findings are not yet practice-changing, they introduce an exciting concept: can adjunctive antiplatelet therapy enhance reperfusion in selected patients who are not candidates for thrombectomy?
The INSTANT trial is an important step toward refining acute stroke therapy beyond recanalization alone.”
Title: Intravenous Tirofiban After Tenecteplase in Acute Ischemic Stroke: The INSTANT Randomized Clinical Trial
Authors: INSTANT Trial Authors for the INSTANT Investigators
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 17, 2026, 02:36Archil Jaliashvili: Oxygen Transport in Capillaries
-
Oct 17, 2026, 02:35Carly Newton: Understanding Access to Red Blood Cell Exchange for People Living With SCD
-
Oct 17, 2026, 02:34Raising Awareness of Blood Clots During and After Pregnancy – Thrombosis UK
-
Oct 17, 2026, 02:33Alaa Salamat: Our Research Accepted for Publication at ASH 2026
-
Oct 17, 2026, 02:32Mohammed Al Sharif: Discussing Factor XIII Testing and Its Clinical Significance
-
Oct 17, 2026, 02:31Joanna Popiolek-Kalisz: Talking about Novel Pharmacotherapy for Hypertension at CV Prevention and Intervention
-
Oct 17, 2026, 02:00How Antiphospholipid Syndrome Can Affect the Adrenal Glands – APS Foundation of America
-
Oct 17, 2026, 01:59Liza-Marie Johnson: How Far Should Clinicians Go to Influence Parents’ Decisions?
-
Oct 17, 2026, 01:54Jim Hoffman: The Importance of Self-Advocacy and Understanding Autoimmune Mechanisms